Cell Press introduced Multi‑Journal Submission (MJS) in 2021 to simplify the publishing process by allowing authors to submit a single manuscript for consideration across multiple journals. Five years later, the system has become a widely adopted pathway for publication, supporting researchers in life, medical, physical, and applied sciences.
The MJS team now includes eight editors, with submissions continuing to rise. New initiatives such as topic collections and monthly featured articles have expanded visibility for authors. According to Cell Press leadership, the system combines innovative editorial workflows with a focus on efficiency while maintaining established quality standards.
Researchers have reported positive experiences with MJS. Erica Ollmann Saphire of the La Jolla Institute for Immunology noted that submitting through MJS allowed her team to engage with multiple editors simultaneously, ensuring their papers found the right journal in a timely manner. Martin Eilers of the University of Würzburg described the peer review process as fast and cohesive, highlighting that his team was offered a choice of publication venues after a single review cycle.
Lead Editor Sejal Vyas explained that MJS is designed to align author preferences with journal fit. In 2025, 70% of accepted papers were published in one of the author’s preferred journals. When manuscripts are not accepted at the first choice, editors suggest alternatives without requiring resubmission. Vyas emphasized that manuscripts are still evaluated independently by each journal’s editorial team, ensuring that scientific merit and journal standards remain central to the process.
Distinctive features of MJS include coordinated peer review, which reduces reviewer burden and provides authors with consistent feedback, and consultative support for navigating revision paths when multiple journals express interest. Editors assist authors in interpreting feedback and choosing the revision direction that best matches their resources and goals.
Five years on, MJS has established itself as an author‑centric system that reduces friction, preserves editorial independence, and supports successful publication outcomes across the Cell Press portfolio.
Click here to read the original press release.
